In 2016, Stanton Glantz co-authored a ridiculous paper, mistakenly published by The Lancet, that massaged data sufficiently to make a bogus claim that vaping made smokers would be 28% less likely to quit if they tried to do so by vaping.
Glantz was quoted, bending the truth: “The irony is that quitting smoking is one of the main reasons both adults and kids use e-cigarettes, but the overall effect is less, not more, quitting. While there is no question that a puff on an e-cigarette is less dangerous than a puff on a conventional cigarette, the most dangerous thing about e-cigarettes is that they keep people smoking conventional cigarettes."
There have been a number of proper UK studies refuting Glantz’ manipulated finding, but Columbia’s will carry more weight in the United States. The study, “Prevalence of population smoking cessation by electronic cigarette use status in a national sample of recent smokers”, has been published in the journal Addictive Behaviours.
- Over half of daily e-cig users in the sample quit smoking in the last 5 years.
- Daily e-cig users were 3 times more likely to be quit than never e-cig users.
- Some day e-cig users were least likely to be quit.
- Some smokers may have quit or are preventing relapse with frequent e-cig use.
The press release states: “After accounting for participants’ desire to quit smoking cigarettes and controlling for other factors known to predict quitting such as educational attainment, health insurance, and age, the probably of having quit was three times higher among daily e-cigarette users compared to never e-cigarette users.”
Doctors Daniel Giovenco and Cristine Delnevo looked at data merged from the 2014 and 2015 National Health Interview Survey. Giovenco, assistant professor of Sociomedical Sciences, said: “While questions regarding the efficacy of e-cigarettes for smoking cessation remain, our findings suggest that frequent e-cigarette use may play an important role in cessation or relapse prevention for some smokers.”
“The FDA recently delayed rules that would have limited e-cigarettes on the market. This indicates that public health officials may be receptive to innovative and lower-risk nicotine products. Uncovering patterns of use at the population level is a critical first step in determining if they may present any benefits to public health.”